References

• 2018Real world data: an opportunity to supplement existing evidence for the use of long-established medicines in health care decision making237 cited
• 2019Examining the Use of Real‐World Evidence in the Regulatory Process166 cited
• 2020Use of Real-World Evidence to Support FDA Approval of Oncology Drugs121 cited
• 2020Use of Real-world Data for New Drug Applications and Line Extensions83 cited
• 2021Understanding Use of Real‐World Data and Real‐World Evidence to Support Regulatory Decisions on Medical Product Effectiveness62 cited
• 2016Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU55 cited
• 2012Quantum of Effectiveness Evidence in FDA’s Approval of Orphan Drugs54 cited

Cited by

No citing works inside the corpus for this window.